Epidermal Growth Factor (EGF) Protein

Details for Product No. ABIN6699794
Protein Name
  • HOMG4
  • URG
  • AI790464
  • CEGF
  • epidermal growth factor
  • pro-epidermal growth factor
  • EGF
  • egf
  • CpipJ_CPIJ020278
  • Egf
Origin
Human
77
40
23
7
4
1
1
Source
Escherichia coli (E. coli)
105
8
5
5
4
4
3
2
2
1
1
1
1
Options
Cross-Reactivity Human
Characteristics Epidermal growth factor, Urogastrone
Purification Purity was determined to be greater than 95% as determined by analysis by RP-HPLC and by reducing and non-reducing SDS-PAGE, against known standard.
Endotoxin Level Low endotoxin
Protein Name
UniProt P01133
Pathways NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Application Notes

Application Note: EGF Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-EGF in immunological assays.

Other Performance Data: Recombinant Human Epidermal Growth Factor is fully biologically active when compared to standards. The ED50, calculated by the dose-dependent proliferation of murine BALB/c 3T3 cells, is 30-40 pg/mL. Endotoxin level as measured by LAL is 0.5EU/μg protein.
Restrictions For Research Use only
Format Lyophilized
Reconstitution

Reconstitution Volume: 5.0 mL

Reconstitution Buffer: Restore with deionized water (or equivalent)
Concentration 0.1 mg/mL
Preservative Without preservative
Storage RT,4 °C,-20 °C
Expiry Date 6 months